EP Biocomposites (543595.BO) Stock Price

EP Biocomposites Price

CLOSED
95.16
​
Market closed

Over the last 5 years EP Biocomposites grew revenue by 84.1% annually, reaching 120.06 M INR. Earnings per share have grown at 100.9% per year over the last 5 years. For EP Biocomposites, the net margin of 8.6% is down versus 12.1% a few years ago.

EP Biocomposites stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EP Biocomposites business model & stock analysis

EP Biocomposites Ltd. manufactures and supplies fibre reinforced polymers (FRP) products including door shutters, frames, laminated doors, biodigester tanks, bio toilets, and FRP allied products such as rooftiles, security cabins, FRP garden benches, and fire hydrant doors. The company builds bio-digesters, sewage treatment plants (STP), effluent treatment plants (ETP), and offers containerized treatment plants for wastewater solutions. Its aqua division serves hotels, industries, institutions, government bodies, and residential and commercial buildings with STP, ETP, and operations and maintenance services. The firm targets construction and industrial sectors requiring sustainable and durable solutions for water treatment and building materials. EP Biocomposites Ltd. sells its FRP products and wastewater treatment solutions directly to construction companies, industrial clients, and government entities. The company’s products are used in projects requiring eco-friendly infrastructure, such as bio-toilets in public spaces and STP systems for hotels and residential complexes. Its fire doors and laminated doors cater to the construction sector’s demand for fire-resistant and durable building materials. The firm’s aqua division focuses on providing comprehensive wastewater management, including STP, ETP, and containerized treatment plants, to clients in the hospitality, industrial, and municipal sectors. EP Biocomposites Ltd. generates revenue through the sale of FRP-based products and the provision of operations and maintenance services for its treatment plants. The company’s offerings align with the growing demand for sustainable infrastructure solutions in both public and private sectors.

Frequently asked questions about EP Biocomposites

Converted at the current exchange rate, the EP Biocomposites share trades at 0.89 EUR (95.16 INR).

The revenue cannot currently be calculated for EP Biocomposites.

The profit cannot currently be calculated for EP Biocomposites.

The P/E ratio cannot be calculated for EP Biocomposites at the moment.

The P/S cannot be calculated for EP Biocomposites currently.

The Eulerpool Quality Score for EP Biocomposites is 4/10.

The ISIN of EP Biocomposites is INE0D2I01014. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of EP Biocomposites is 543595.BO. The ticker symbol is used to trade EP Biocomposites shares on the stock exchange.

Fair ValueTerminal
79.93 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Building Products
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Sep 13, 2022
ISIN
INE0D2I01014
Cusip
Y229FH104
Market capitalization
159.87 M INRMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
10.43
P/B Ratio
1.51
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7.59 %
Last updated Oct 27, 2026, 11:05 AM

EP Biocomposites Peer Group

EP Biocomposites FIGI

EPBIO:IN · BBG019CFGG09EPBIO:IB · BBG019CFGG18

All fundamentals and in-depth analysis of EP Biocomposites

Our stock analysis for EP Biocomposites stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EP Biocomposites. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.